Galderma Reports Strong Nine-Month 2026 Results and Raises Full-Year Guidance

Galderma reported net sales of 4.765 billion USD for the first nine months of 2026, representing a 25.1% year-on-year increase on a constant currency basis. The company has raised its full-year net sales guidance following this strong performance, which is attributed to continued growth in its dermatology portfolio. The announcement was made on October 22, 2026.